Comparison

Sitagliptin European Partner

Item no. TMO-T0242-10mM
Manufacturer TargetMol
CASRN 486460-32-6
Amount 1 mL x 10 mM (in DMSO)
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 200 mg 25 mg 2 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias MK0431
Shipping Condition Cool pack
Available
Manufacturer - Targets
Autophagy|||Proteasome|||DPP-4
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
407.31
Description
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or in combination with metformin or thiazolidinedione for treatment of type 2 diabetes mellitus. The drug can competitively inhibit a protein/enzyme and DPP-4, that leads to an incremental amount of active incretins (GLP-1 and GIP), the diminished amount of release of glucagon and increased release of insulin.
Pathways
Proteases/Proteasome|||Autophagy|||Ubiquitination
Formulate
C16H15F6N5O

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL x 10 mM (in DMSO)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close